Ryman T, Petersson J, Andersson K E, Brandt L, Högestätt E D
Department of Clinical Pharmacology, University Hospital of Lund, Sweden.
Naunyn Schmiedebergs Arch Pharmacol. 1993 Sep;348(3):298-304. doi: 10.1007/BF00169159.
The effect of pinacidil on the contractile response to stepwise increases of the extracellular K+ concentration ([K+]o) was investigated in isolated segments of human pial and mesenteric arteries and rabbit basilar and mesenteric arteries. The [K+]o eliciting half maximum contraction (EC50) was lower in human pial (18 mM) and rabbit basilar (27 mM) arteries than in human (33 mM) and rabbit (32 mM) mesenteric arteries, respectively. The alpha-adrenoceptor blocker, prazosin, increased the EC50 value for K+ from 27 to 40 mM and reduced the maximum response in rabbit mesenteric arteries, but had no effect on the K(+)-induced contraction in rabbit basilar arteries, indicating a substantial noradrenergic component of the K+ response in the former arteries. Removal of the endothelium decreased the EC50 value for K+ from 27 to 15 mM in rabbit basilar arteries, whereas the K+ sensitivity was unaffected in rabbit mesenteric arteries. Pinacidil shifted the K+ concentration-response curve to the right in human and rabbit cerebral and mesenteric arteries. In rabbit basilar arteries, but not in mesenteric arteries, the shift was larger in the absence than in the presence of an intact endothelium. When endothelium-denuded rabbit arteries were compared, the inhibitory effect of pinacidil was larger in basilar than in mesenteric arteries. Thus, pinacidil inhibits K(+)-induced contractions in both cerebral and mesenteric arteries, but appears to act preferentially on endothelium-denuded rabbit basilar arteries. Provided that endothelial damage and depolarization-induced vasoconstriction are of pathophysiological importance in cerebrovascular disorders such as stroke and cerebral ischemia secondary to vasospasm after subarachnoid hemorrhage, pinacidil may have a therapeutic potential.
在人软脑膜动脉和肠系膜动脉以及兔基底动脉和肠系膜动脉的离体节段中,研究了吡那地尔对细胞外钾离子浓度([K⁺]o)逐步升高时收缩反应的影响。引起半数最大收缩(EC50)的[K⁺]o在人软脑膜动脉(18 mM)和兔基底动脉(27 mM)中分别低于人肠系膜动脉(33 mM)和兔肠系膜动脉(32 mM)。α-肾上腺素受体阻滞剂哌唑嗪使兔肠系膜动脉中钾离子的EC50值从27 mM增加到40 mM,并降低了最大反应,但对兔基底动脉中钾离子诱导的收缩没有影响,表明前一种动脉中钾离子反应有大量去甲肾上腺素能成分。去除内皮后,兔基底动脉中钾离子的EC50值从27 mM降至15 mM,而兔肠系膜动脉中的钾离子敏感性未受影响。吡那地尔使人和兔脑动脉及肠系膜动脉的钾离子浓度-反应曲线右移。在兔基底动脉中,而非肠系膜动脉中,无内皮时的曲线右移幅度大于有完整内皮时。当比较内皮剥脱的兔动脉时,吡那地尔对基底动脉的抑制作用大于肠系膜动脉。因此,吡那地尔抑制脑动脉和肠系膜动脉中钾离子诱导的收缩,但似乎优先作用于内皮剥脱的兔基底动脉。鉴于内皮损伤和去极化诱导的血管收缩在诸如中风和蛛网膜下腔出血后血管痉挛继发的脑缺血等脑血管疾病中具有病理生理学重要性,吡那地尔可能具有治疗潜力。